Faculty of Medicine, University of Oslo, Oslo, Norway
Search for other papers by Espen Nordheim in
Google Scholar
PubMed
Faculty of Medicine, University of Oslo, Oslo, Norway
Metabolic and Renal Research Group, Faculty of Health Sciences, UiT- The Arctic University of Norway, Tromsø
Search for other papers by Trond Geir Jenssen in
Google Scholar
PubMed
Introduction Diabetes mellitus is among the leading causes of chronic kidney disease and end-stage kidney disease in the western world. It was the most common diagnosis for the initiation of renal replacement therapy in the United States in
Search for other papers by Qingrong Pan in
Google Scholar
PubMed
Search for other papers by Shuxin Gao in
Google Scholar
PubMed
Search for other papers by Xia Gao in
Google Scholar
PubMed
Search for other papers by Ning Yang in
Google Scholar
PubMed
Search for other papers by Zhi Yao in
Google Scholar
PubMed
Search for other papers by Yanjin Hu in
Google Scholar
PubMed
Search for other papers by Li Miao in
Google Scholar
PubMed
Search for other papers by Zhe Chen in
Google Scholar
PubMed
Search for other papers by Guang Wang in
Google Scholar
PubMed
shown that both subclinical hypothyroidism and hypothyroidism were associated with elevated serum creatinine, decreased estimated glomerular filtration rate (eGFR) and increased risk of chronic kidney disease (CKD) ( 4 , 5 , 6 , 7 ). Moreover, the
Search for other papers by Martine Cohen-Solal in
Google Scholar
PubMed
Search for other papers by Thomas Funck-Brentano in
Google Scholar
PubMed
Department of Renal Physiology, Necker Hospital, Université de Paris, Paris, France
Search for other papers by Pablo Ureña Torres in
Google Scholar
PubMed
Introduction Chronic kidney disease (CKD) is associated with a high morbidity and mortality, in which skeletal complications are predominant. Mineral and bone diseases (MBD) observed in CKD are now joint entities called CKD-MBD, which refers
Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China
Department of Ultrasound, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China
Search for other papers by Riying Liang in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China
Search for other papers by Meijun Wang in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China
Search for other papers by Chang Fu in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China
Search for other papers by Hua Liang in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China
Search for other papers by Hongrong Deng in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China
Search for other papers by Ying Tan in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China
Search for other papers by Fen Xu in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China
Search for other papers by Mengyin Cai in
Google Scholar
PubMed
Introduction Chronic kidney disease (CKD) is increasing worldwide, and obesity is a major risk factor for the development of CKD ( 1 , 2 ) that could be independent of hypertension, diabetes, and dyslipidemia ( 3 ). The pathological features
Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands
Search for other papers by Anna C van der Burgh in
Google Scholar
PubMed
Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands
Search for other papers by Samer R Khan in
Google Scholar
PubMed
Search for other papers by Sebastian J C M M Neggers in
Google Scholar
PubMed
Search for other papers by Ewout J Hoorn in
Google Scholar
PubMed
Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands
Search for other papers by Layal Chaker in
Google Scholar
PubMed
Introduction Chronic kidney disease (CKD) is a highly prevalent condition ( 1 ) and is often characterized by a decline in kidney function over time. Generally, a higher prevalence of CKD is found in women, while men with CKD have a higher
Search for other papers by Yunyi Ding in
Google Scholar
PubMed
Search for other papers by Siyao Lv in
Google Scholar
PubMed
Search for other papers by Ruijie Xie in
Google Scholar
PubMed
Search for other papers by Wei Ye in
Google Scholar
PubMed
Search for other papers by Yichen Luo in
Google Scholar
PubMed
Search for other papers by Yayu Li in
Google Scholar
PubMed
kidney disease (DKD), diabetic retinopathy, and cardiovascular and cerebrovascular disease. These complications are intimately associated with an augmentation in disability rates, a diminution in the quality of life, and a contraction in life expectancy
Search for other papers by L E Zijlstra in
Google Scholar
PubMed
Search for other papers by D M van Velzen in
Google Scholar
PubMed
Search for other papers by S Simsek in
Google Scholar
PubMed
Search for other papers by S P Mooijaart in
Google Scholar
PubMed
Department of Internal Medicine, HagaHospital, The Hague, The Netherlands
Search for other papers by M van Buren in
Google Scholar
PubMed
Search for other papers by D J Stott in
Google Scholar
PubMed
Search for other papers by I Ford in
Google Scholar
PubMed
Search for other papers by J W Jukema in
Google Scholar
PubMed
Department of Internal Medicine, Section of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by S Trompet in
Google Scholar
PubMed
mortality ( 5 , 6 , 7 ). Chronic kidney disease (CKD) is accompanied by a substantial cardiovascular disease risk ( 8 , 9 ). Associations of thyroid hormones and CKD have also been described. Multiple cross-sectional studies have linked lower thyroid
Search for other papers by Yinqiong Huang in
Google Scholar
PubMed
Department of Endocrinology, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China
Search for other papers by Zhaozhao Zhu in
Google Scholar
PubMed
Search for other papers by Zhiqin Huang in
Google Scholar
PubMed
Search for other papers by Jingxiong Zhou in
Google Scholar
PubMed
Introduction Diabetic kidney disease (DKD) is one of the most common and important microvascular complications of diabetes, with more than 25–40% of diabetic patients developing nephropathy 20–35 years after the onset of the disease ( 1 ). DKD
Search for other papers by Chun-feng Lu in
Google Scholar
PubMed
Search for other papers by Wang-shu Liu in
Google Scholar
PubMed
Search for other papers by Xiao-qin Ge in
Google Scholar
PubMed
Search for other papers by Feng Xu in
Google Scholar
PubMed
cases in China ( 2 ). Diabetic kidney disease (DKD), one of the most common diabetic microvascular complications, is a major cause of the end-stage renal disease (ESRD) and is associated with increased mortality in diabetic patients ( 3 ). As the
Department of Endocrinology and Internal Medicine, Novo Nordisk A/S, NNF center for Basic Metabolic Research, Department of Clinical Biochemistry, Department of Clinical Physiology and Molecular Imaging, Department of Clinical Medicine, Aarhus University Hospital, Norrebrogade 44, DK-8000 Aarhus, Denmark
Search for other papers by Jeppe Skov in
Google Scholar
PubMed
Search for other papers by Jens Juul Holst in
Google Scholar
PubMed
Search for other papers by Jens Peter Gøtze in
Google Scholar
PubMed
Department of Endocrinology and Internal Medicine, Novo Nordisk A/S, NNF center for Basic Metabolic Research, Department of Clinical Biochemistry, Department of Clinical Physiology and Molecular Imaging, Department of Clinical Medicine, Aarhus University Hospital, Norrebrogade 44, DK-8000 Aarhus, Denmark
Search for other papers by Jørgen Frøkiær in
Google Scholar
PubMed
Search for other papers by Jens Sandahl Christiansen in
Google Scholar
PubMed
conditions. Fourteen subjects were screened, one withdrew after screening and one was excluded after the study because of fluid retention due to impaired urinations. Protocol The primary study objective was to investigate GLP1-induced effects on kidney